In vivo application of biodegradable controlled antibiotic release systems for the treatment of implant-related osteomyelitis
- 1 January 2000
- journal article
- Published by Elsevier BV in Biomaterials
- Vol. 22 (1), 73-80
- https://doi.org/10.1016/s0142-9612(00)00170-8
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Characterization of a rabbit model of staphylococcal osteomyelitisJournal of Orthopaedic Research, 1997
- Delayed Local Treatment of Rabbit Tibial Fractures With Biodegradable Cefazolin MicrospheresPublished by Ovid Technologies (Wolters Kluwer Health) ,1997
- A novel drug delivery system for osteomyelitis using porous hydroxyapatite blocks loaded by centrifugationJournal of Applied Biomaterials, 1995
- Properties and drug release behaviour of poly(3-hydroxybutyric acid) and various poly(3-hydroxybutyrate-hydroxyvalerate) copolymer microcapsulesJournal of Microencapsulation, 1995
- A novel skeletal drug delivery system for anti-bacterial drugs using self-setting hydroxyapatite cement.CHEMICAL & PHARMACEUTICAL BULLETIN, 1990
- Gentamicin-loaded Plaster of Paris as a Treatment of Experimental Osteomyelitis in RabbitsPublished by Ovid Technologies (Wolters Kluwer Health) ,1987
- Biodegradable Bone Repair MaterialsPublished by Ovid Technologies (Wolters Kluwer Health) ,1986
- Antibiotic-loaded Acrylic CementPublished by Ovid Technologies (Wolters Kluwer Health) ,1984
- Use of Antibiotic-containing Bone CementPublished by Ovid Technologies (Wolters Kluwer Health) ,1984
- Treatment of Chronic Osteomyelitis by Necrectomy and Gentamicin-PMMA BeadsPublished by Ovid Technologies (Wolters Kluwer Health) ,1981